Haemostasis is the process that limits blood loss after a vessel is injured. For MRCEM Primary revision, begin with what each component does: platelets form an initial plug, coagulation reinforces it with fibrin, and fibrinolysis helps remove fibrin as repair progresses. This framework is more useful than starting with an isolated list of clotting factors.
Once these functions are clear, laboratory questions become easier to reason through. A platelet count answers a different question from a clotting time. A normal result does not establish that every part of haemostasis works normally, and a prolonged result does not automatically establish a bleeding tendency. Fit this topic into your MRCEM Primary revision plan by learning the mechanism first and using the cases below to check your understanding.
1. What haemostasis achieves
The three connected processes
At an injured vessel, haemostasis must create a local seal while preserving circulation elsewhere. Platelets, coagulation and fibrinolysis work together. The labels “primary” and “secondary” are useful for learning, but they should not imply that one process must completely finish before another begins.The hemostatic system: research review
Process | Main learning point |
|---|---|
Primary haemostasis | Platelets adhere, activate and aggregate to form a plug. |
Secondary haemostasis | Coagulation generates thrombin and fibrin, reinforcing the plug. |
Fibrinolysis | Plasmin degrades fibrin; clot breakdown is regulated. |
How much detail does MRCEM Primary require?
The updated RCEM Basic Sciences Syllabus includes haemostasis and states that detailed knowledge of the coagulation cascade is not required. It applies from the 21 April 2027 examination. Prioritise the roles of platelets, thrombin and fibrin. The PT/APTT and mixing-study sections below are supporting applied learning, rather than a claim that every specialist laboratory detail must be memorised.RCEM: new syllabus launched, 28 October 2026
2. Primary haemostasis: building the platelet plug
Adhesion, activation and aggregation
Use three verbs. Adhesion means platelets attach at the site of vessel injury. Activation means they respond and recruit further platelets. Aggregation means platelets join together to build the plug. Keeping these actions separate helps you explain a defect instead of merely naming it.
Platelet aggregation is an important defence against bleeding. It can be impaired by inherited abnormalities, acquired illness or platelet-inhibiting medicines such as aspirin. This is why the medication history belongs in the interpretation of bleeding symptoms.North West London Pathology: platelet function studies
Why platelet count is not platelet function
A platelet count tells you how many platelets are circulating; it does not directly measure whether they can form an effective plug. Imagine counting the workers arriving at a repair site: the number alone cannot establish that their tools and coordination work. The same distinction explains why a normal count does not exclude a platelet-function disorder.
In an SBA, read the requested quantity carefully. If the question asks about impaired platelet function, choosing an answer solely because it lowers the platelet count may miss the mechanism. For related drug concepts, see the broader pharmacology revision overview.
The two roles of von Willebrand factor
Von Willebrand factor supports platelet adhesion and carries factor VIII in plasma. These roles connect primary haemostasis with coagulation. Reduced or abnormal von Willebrand factor can impair platelet adhesion; factor VIII may also fall.North West London Pathology: von Willebrand screen
A history of recurrent nosebleeds, easy bruising, heavy menstrual bleeding or excessive bleeding after procedures can suggest von Willebrand disease. The diagnosis requires appropriate specialist blood tests and clinical assessment; the symptom pattern alone is not specific.NHS: von Willebrand disease
3. Secondary haemostasis and fibrinolysis
Thrombin makes fibrin
The key distinction is between fibrinogen, the soluble precursor, and fibrin, the material that helps stabilise the clot. Thrombin drives the conversion. If a question asks which enzyme converts fibrinogen into fibrin, the answer is thrombin. Do not confuse the enzyme with the product it creates.South Tees: thrombin time
A useful retrieval exercise is to complete this sentence without notes: “Thrombin converts ___ into ___.” Then explain how that helps a platelet plug withstand blood flow. This tests the functional relationship rather than recognition of three familiar words.
Plasmin breaks fibrin down
Fibrinolysis involves conversion of plasminogen into plasmin, followed by degradation of fibrin. Tissue plasminogen activator is one activator involved in this process. Tranexamic acid inhibits fibrinolysis by interfering with relevant binding interactions; it is not a replacement for platelets or missing clotting factors.Valke et al: Fibrinolytic assays in bleeding of unknown cause (2022)
Keep formation and breakdown in separate columns when revising: thrombin is associated with generating fibrin, while plasmin is associated with degrading it. Knowing a drug’s mechanism does not, by itself, establish when it should be prescribed; this article focuses on the underlying science.
4. Supporting application: what PT and APTT measure
A laboratory map, not a complete bleeding assessment
PT and APTT measure clotting under defined laboratory conditions. The traditional pathway model helps organise their sensitivity. It is a useful map for interpreting results, but it does not capture the full interaction between circulating blood, platelets and the vessel wall.
Test | Main association | Important limitation |
|---|---|---|
PT | Extrinsic and common pathways; factor VII is a useful extrinsic-pathway anchor. | An abnormal PT is a pattern requiring an explanation, not a diagnosis. |
APTT | Intrinsic and common pathways. | Can be prolonged by deficiencies, inhibitors or anticoagulants. |
Thrombin time | Final conversion of fibrinogen into fibrin after thrombin is added. | Prolongation can reflect abnormal fibrinogen or an inhibitory effect. |
The INR is derived from PT and is used to monitor vitamin K antagonist treatment such as warfarin. APTT is used in some unfractionated-heparin monitoring protocols; it is not an appropriate way to monitor low-molecular-weight heparin.North West London Pathology: coagulation screen · South Tees: thrombin time
Read patterns alongside the history
PT / APTT pattern | Examples to consider |
|---|---|
PT prolonged, APTT normal | Factor VII deficiency; early vitamin K-related effects may predominantly affect PT. |
PT normal, APTT prolonged | Intrinsic-pathway factor deficiency, inhibitor or heparin effect. |
Both prolonged | Multiple-factor problems, common-pathway abnormalities, advanced liver disease or DIC, depending on context. |
Both normal | Does not exclude platelet dysfunction, some von Willebrand disease, mild factor deficiency or factor XIII deficiency. |
These are starting points, not exclusive diagnostic boxes. Interpret them alongside bleeding history, medication exposure, platelet count and other relevant results. The sepsis and septic shock guide covers a clinical setting in which coagulopathy may arise; identifying DIC requires more than recognising two prolonged clotting times.South Tees: Haematology Handbook, abnormal coagulation, page 27
Check the specimen and medicines
Before constructing an elaborate diagnosis from an unexpected result, consider the sample. Citrate tubes must be filled correctly because the blood-to-anticoagulant ratio matters. Underfilled or clotted specimens may be rejected, and an unexplained abnormal screen may require repeat sampling before further investigation.Worcestershire Acute Hospitals: mixing studies and sample requirements
Also check anticoagulant exposure. A normal PT and APTT do not reliably exclude significant circulating concentrations of a direct oral anticoagulant. Their effects depend on the drug and assay; do not interpret a normal screen as proof that an anticoagulant has worn off.NHS Highland: anticoagulants and invasive procedures
5. Supporting application: when the screen misleads
Normal results with bleeding
PT and APTT do not test every cause of bleeding. Platelet-function disorders and some cases of von Willebrand disease can occur with normal screening clotting times. Factor XIII deficiency is another example of a bleeding disorder that can escape the routine screen. A convincing bleeding history therefore remains relevant even when PT and APTT are within range.South Tees: Haematology Handbook, abnormal coagulation, page 27
Prolonged results without bleeding
Factor XII deficiency provides the reverse lesson: the APTT is prolonged, but the deficiency does not cause a bleeding disorder. This is a useful exception because it breaks the shortcut “long clotting time equals clinical bleeding”. The result describes an assay response; its clinical significance depends on the underlying cause.Newcastle Hospitals: factor XII assay
What mixing studies add
A mixing study combines patient plasma with normal plasma, commonly in equal proportions. The laboratory asks whether adding normal plasma corrects the prolonged clotting time. Correction supports a factor deficiency; failure to correct raises the possibility of an inhibitor or an interfering anticoagulant. These are interpretive clues, not definitive diagnoses.Leeds Teaching Hospitals: coagulation mixing studies · South Tees: Haematology Handbook, abnormal coagulation, page 27
Timing matters. A time-dependent inhibitor can allow initial correction, followed by renewed prolongation after incubation. An immediate result alone may therefore mislead. Specialist interpretation integrates the immediate and incubated results, medication history and further assays.Gloucestershire Hospitals: time-dependent inhibitor screen
6. Five original practice SBAs
These questions were written for this article. They are educational practice, not recalled or official RCEM questions. Questions 4 and 5 extend the core physiology into laboratory interpretation.
Question 1: platelet count versus function
A patient taking aspirin has a normal platelet count. Which statement best describes what the count establishes?
A. Platelet aggregation must be normal.
B. All causes of impaired primary haemostasis are excluded.
C. The circulating platelet number is within the laboratory reference interval.
D. Fibrin formation is normal.
E. Von Willebrand factor function is normal.
Answer: C. The result establishes the platelet number, not its functional quality. A and B incorrectly treat count as function. D concerns coagulation rather than platelet enumeration. E requires different testing.North West London Pathology: platelet function studies
Question 2: a bridging protein
Which pair of functions is most closely associated with von Willebrand factor?
A. Platelet adhesion and carriage of factor VIII.
B. Fibrin breakdown and plasminogen activation.
C. Conversion of fibrinogen to fibrin and breakdown of fibrin.
D. Platelet production and erythropoietin release.
E. Vitamin K recycling and inhibition of thrombin.
Answer: A. Von Willebrand factor assists adhesion and carries factor VIII. B describes fibrinolytic functions. C combines the actions associated with thrombin and plasmin. D concerns blood-cell production and a renal hormone. E does not describe von Willebrand factor.North West London Pathology: von Willebrand screen
Question 3: fibrin formation
Which substance directly converts fibrinogen into fibrin?
A. Plasmin.
B. Von Willebrand factor.
C. Plasminogen.
D. Thrombin.
E. Tissue plasminogen activator.
Answer: D. Thrombin acts on fibrinogen. Plasmin degrades fibrin, whereas plasminogen is its precursor. Tissue plasminogen activator promotes plasmin formation. Von Willebrand factor supports adhesion and factor VIII carriage.South Tees: thrombin time · Valke et al: Fibrinolytic assays in bleeding of unknown cause (2022)
Question 4: an abnormal result without bleeding
An asymptomatic adult has a repeatedly prolonged APTT, normal PT and no abnormal bleeding after previous operations. A specific factor assay confirms factor XII deficiency. Which conclusion is most accurate?
A. The factor deficiency necessarily causes severe bleeding.
B. Factor XII deficiency can prolong APTT without causing a bleeding disorder.
C. The normal PT proves every component of haemostasis is normal.
D. A prolonged APTT establishes haemophilia A.
E. Factor XII deficiency must lower the platelet count.
Answer: B. This is the characteristic distinction in factor XII deficiency. A assumes laboratory prolongation predicts bleeding. C overinterprets PT. D treats a non-specific pattern as a diagnosis. E confuses a plasma-factor deficiency with platelet number.Newcastle Hospitals: factor XII assay
Question 5: why incubation matters
A prolonged APTT initially corrects when patient plasma is mixed with normal plasma. After incubation, the APTT of the mixture becomes prolonged again. Which interpretation best explains this pattern?
A. A factor deficiency is definitively confirmed.
B. All coagulation inhibitors are excluded.
C. The platelet count must be low.
D. The original PT must have been prolonged.
E. A time-dependent inhibitor should be considered.
Answer: E. Loss of correction after incubation suggests a time-dependent inhibitor. A and B ignore the delayed result. C cannot be inferred from a plasma mixing test, and D is not required for this APTT pattern. The result needs specialist interpretation rather than an automatic diagnosis.Gloucestershire Hospitals: time-dependent inhibitor screen · Leeds Teaching Hospitals: coagulation mixing studies
7. Consolidate and practise
A short retrieval exercise
Close the article and explain platelet adhesion, activation and aggregation in one sentence each. Next, distinguish fibrinogen from fibrin and thrombin from plasmin. Finally, give one example of bleeding with a normal screen and one example of an abnormal screen without a bleeding disorder.
When you review an incorrect answer, identify the exact confusion: number versus function, formation versus breakdown, or test result versus clinical conclusion. Write a short corrective sentence and revisit it during your next revision session.
Continue with StudyMedical
Apply these principles using the StudyMedical MRCEM Primary question bank. It offers over 7,800 questions, explanations with teaching diagrams, topic-based custom quizzes, timed quizzes and the option to revisit previously incorrect questions. Try free sample questions without signing up before choosing a plan.
